AHA, AARP CEOs Highlight ‘Exorbitantly-priced Drugs’ in Hill OpEd
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system. “Ultimately, the current system of exorbitantly-priced drugs is unsustainable for everyone — patients, employers, insurers, and taxpayer-funded programs like Medicare and Medicaid,” they wrote. “We stand ready to work together to find commonsense and innovative solutions that will help make drugs affordable for everyone.” Read more.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Sept. 30 finalized its Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model. The…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.…
Headline
The deadline to apply for the inaugural AHA Age-Friendly Healthcare Impact Award is Sept. 25. The award, created by the AHA and The John A. Hartford Foundation…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 18 that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in its…
Headline
The National Institutes of Health has launched its Connecting the Community for Maternal Health Challenge: Research Capacity Building in Maternity Care Deserts…
Headline
The Trump administration announced Aug. 31 agreements with nine additional pharmaceutical manufacturers aimed at lowering prescription drug prices through a…